Polymyxin B Sulfate/Bacitracin/Fradiomycin sulfate/Lidocaine Hydrochloride

硫酸多粘菌素B/杆菌肽/硫酸新霉素/盐酸利多卡因

Report date: 2025/07/22 15:55:15

Base Information

Drug NamePolymyxin B Sulfate/Bacitracin/Fradiomycin sulfate/Lidocaine Hydrochloride
Drug Alias Name复方多粘菌素B
ClassificationSmall molecules
Mechanisms of ActionCell membrane function inhibitorsBacterial penicillin-binding protein inhibitorsSodium channel alpha subunit blockers
TargetsBacterial penicillin-binding proteinSodium channel alpha subunit
Therapy Area/IndicationsInfections
Global Approved IndicationsInfections
Approved Indications in ChinaInfections
Original Approved Country/TerritoryUnited States
Original Approved Date1985/06/03
Country/TerritoryUnited StatesMainland China
CombinationsYes Polymyxin B SulfateBacitracinFradiomycin sulfate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Medicare Pharmaceutical Co Ltd
Inactive CompaniesCombe Inc
Active IndicationsInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A